Benzinga | Jul 29, 2021 04:34PM EDT

Corcept Therapeutics Q2 Adj. EPS $0.30 Down From $0.32 YoY, Sales $91.60M Up From $88.56M YoY; Reaffirms FY21 Sales Guidance $355M-$385M vs $370.7M Est.

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.30 per share. This is a 6.25 percent decrease over earnings of $0.32 per share from the same period last year. The company reported $91.60 million in sales this quarter. This is a 3.43 percent increase over sales of $88.56 million the same period last year.